Abstract
Kidney disease is commonly found in heart failure (HF) patients. They share many risk factors and common pathophysiological pathways which often lead to mutual dysfunction. Both haemodynamic and non-haemodynamic mechanisms are involved in the development of renal impairment in heart failure patients. Moreover, the presence of a chronic kidney disease is a significant independent predictor of worse outcome in chronic as well as in acute decompensated HF. As a consequence, an accurate evaluation of renal function plays a key role in the management of HF patients. Serum creatinine levels and glomerular filtration rate (GFR) estimates are the corner stones of renal function evaluation in clinical practice. However, to overcome their limits, several emerging glomerular and tubular biomarkers have been proposed over the last years. Alongside the renal biomarkers, imaging techniques could complement the laboratory data exploring different pathophysiological pathways. In particular, Doppler evaluation of renal circulation is a highly feasible technique that can effectively identify HF patients prone to develop renal dysfunction and with a worse outcome. Finally, some classes of drugs currently used in heart failure treatment can affect renal function and their use can be influenced by the presence of chronic kidney disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT et al (2005) ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry. Am Heart J 149:209–216
Alhaj E, Alhaj N, Rahman I, Niazi TO, Berkowitz R, Klapholz M (2013) Uremic cardiomyopathy: an underdiagnosed disease. Congest Heart Fail 19:E40–E45
Alvelos M, Lourenço P, Dias C, Amorim M, Rema J, Leite AB et al (2013) Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure. Int J Cardiol 165:51–55
Arimoto T, Takeishi Y, Niizeki T, Takabatake N, Okuyama H, Fukui A et al (2005) A novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure. J Card Fail 11:595–601
Aronson D, Mittleman MA, Burger AJ (2004) Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 116:466–473
Artunc F, Rossi C, Boss A (2011) MRI to assess renal structure and function. Curr Opin Nephrol Hypertens 20:669–675
Bauer JA, Fung HL (1991) Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure. Circulation 84:35–39
Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P (1987) Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57:17–22
Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M et al (2002) Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 17:1890–1896
Boss A, Martirosian P, Gehrmann M, Artunc F, Risler T, Oesingmann N et al (2007) Quantitative assessment of glomerular filtration rate with MR gadolinium slope clearance measurements: a phase I trial. Radiology 242:783–790
Bowling CB, Sanders PW, Allman RM, Rogers WJ, Patel K, Aban IB et al (2012) Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD treatment trial. Int J Cardiol 167:151–156
Braam B, Cupples WA, Joles JA, Gaillard C (2012) Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev 17:161–175
Bude RO, Rubin JM (1999) Relationship between the resistive index and vascular compliance and resistance. Radiology 211:411–417
Cauthen CA, Lipinski MJ, Abbate A, Appleton D, Nusca A, Varma A (2008) Relation of blood urea nitrogen to long-term mortality in patients with heart failure. Am J Cardiol 101:1643–1647
Chade AR (2013) Renal vascular structure and rarefaction. Compr Physiol 3:817–883
Chang SM, Granger CB, Johansson PA, Kosolcharoen P, McMurray JJ, Michelson EL, CHARM Investigators et al (2010) Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart Failure–Assessment of Reduction in Mortality and Morbidity (CHARM) programme. Eur J Heart Fail 12:738–745
Charloux A, Piquard F, Doutreleau S, Brandenberger G, Geny B (2003) Mechanisms of renal hyporesponsiveness to ANP in heart failure. Eur J Clin Invest 33:769–778
Chong VH, Singh J, Parry H, Saunders J, Chowdhury F, Mancini DM et al (2015) Management of noncardiac comorbidities in chronic heart failure. Cardiovasc Ther 33:300–315
Ciccone MM, Iacoviello M, Gesualdo L, Puzzovivo A, Antoncecchi V, Doronzo A et al (2014) The renal arterial resistance index: a marker of renal function with an independent and incremental role in predicting heart failure progression. Eur J Heart Fail 16:210–216
Coca SG, Krumholz HM, Garg AX, Parikh CR (2006) Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296:1377–1384
Cogan JJ, Humphreys MH, Carlson CJ, Rapaport E (1980) Renal effects of nitroprusside and hydralazine in patients with congestive heart failure. Circulation 61:316–323
Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE et al (1986) Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 314:1547–1552
Collins SP, Hart KW, Lindsell CJ, Fermann GJ, Weintraub NL, Miller KF et al (2012) Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events. Eur J Heart Fail 14:1020–1029
Colombo PC, Ganda A, Lin J, Onat D, Harxhi A, Iyasere JE et al (2012) Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev 17:177–190
Comper WD, Hilliard LM, Nikolic-Paterson DJ, Russo LM (2008) Disease-dependent mechanisms of albuminuria. Am J Physiol Renal Physiol 295:F1589–F1600
Damman K, Testani JM (2015) The kidney in heart failure: an update. Eur Heart J 36:1437–1444
Damman K, Jaarsma T, Voors AA, Navis G, Hillege HL, van Veldhuisen DJ (2009a) Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 11:847–854
Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2009b) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53:582–588
Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD, Westenbrink BD et al (2010) Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96:1297–1302
Damman K, Masson S, Hillege HL, Maggioni AP, Voors AA, Opasich C et al (2011) Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J 32:2705–2712
Damman K, Voors AA, Navis G, van Veldhuisen DJ, Hillege HL (2012) Current and novel renal biomarkers in heart failure. Heart Fail Rev 17:241–250
Damman K, Valente MA, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL (2014a) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35:455–469
Damman K, Tang WH, Felker GM, Lassus J, Zannad F, Krum H et al (2014b) Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data. J Am Coll Cardiol 63:853–871
Darmon M, Schnell D, Zeni F (2010) Doppler based renal resistive index: a comprehensive review. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Heidelberg, pp 331–338
de Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K et al (2009) Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care 32:1833–1838
Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221–226
Di Lullo L, Floccari F, Granata A, D’Amelio A, Rivera R, Fiorini F et al (2012) Ultrasonography: Ariadne’s thread in the diagnosis of the Cardiorenal syndrome. Cardiorenal Med 2:11–17
Ellison DH (2001) Diuretic therapy and resistance in congestive heart failure. Cardiology 96:132–143
Emamian SA, Nielsen MB, Pedersen JF, Ytte L (1993) Kidney dimensions at sonography: correlation with age, sex, and habitus in 665 adult volunteers. AJR Am J Roentgenol 160:83–86
Ennezat PV, Maréchaux S, Six-Carpentier M, Pinçon C, Sediri I, Delsart P et al (2011) Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction. Nephrol Dial Transplant 26:3908–3913
Eshaghian S, Horwich TB, Fonarow GC (2006) Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 97:1759–1764
Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ (2012) Diuretics for heart failure. Cochrane Database Syst Rev 2:CD003838
Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ, ADHERE, Scientific Advisory Committee, Study Group, and Investigators (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293:572–580
Fricker M, Wiesli P, Brändle M, Schwegler B, Schmid C (2003) Impact of thyroid dysfunction on serum cystatin C. Kidney Int 63:1944–1947
Garg R, Yusuf S (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 273:1450–1456
Giamouzis G, Butler J, Triposkiadis F (2011) Renal function in advanced heart failure. Congest Heart Fail 17:180–188
Goldsmith SR, Sobotka PA, Bart BA (2010) The sympathorenal axis in hypertension and heart failure. J Card Fail 16:369–373
Granata A, Clementi A, Virzì GM, Brocca A, de Cal M, Scarfia VR et al (2016) Cardiorenal syndrome type 4: from chronic kidney disease to cardiovascular impairment. Eur J Intern Med 30:1–6
Granger CB, McMurray JJV, Yusuf S, Held P, Michelson EL, Olofsson B et al (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative trial. Lancet 362:772–776
Hackstein N, Heckrodt J, Rau WS (2003) Measurement of single-kidney glomerular filtration rate using a contrast-enhanced dynamic gradient-echo sequence and the Rutland-Patlak plot technique. J Magn Reson Imaging 18:714–725
Hackstein N, Wiegand C, Rau WS, Langheinrich AC (2004) Glomerular filtration rate measured by using triphasich elical CT with a two-point Patlak plot technique. Radiology 230:221–226
Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV (2002) Kidney injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62:237–244
Hanamura K, Tojo A, Kinugasa S, Asaba K, Fujita T (2012) The resistive index is a marker of renal function, pathology, prognosis, and responsiveness to steroid therapy in chronic kidney disease patients. Int J Nephrol 2012:139565
Haufe SE, Riedmüller K, Haberkorn U (2006) Nuclear medicine procedures for the diagnosis of acute and chronic renal failure. Nephron Clin Pract 103:c77–c84
Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J, ADHERE Scientific Advisory Committee and Investigators (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13:422–430
Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS et al (2016) Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One 11:e0158765
Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A et al (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203–210
Iacoviello M, Doronzo A, Paradies V, Antoncecchi V, Monitillo F, Citarelli G et al (2015) The independent association between altered renal arterial resistance and loop diuretic dose in chronic heart failure outpatients. IJC Heart & Vasculature 7:119–123
Iacoviello M, Monitillo F, Leone M, Citarelli G, Doronzo A, Antoncecchi V et al (2016) The renal arterial resistance index predicts worsening renal function in chronic heart failure patients. Cardiorenal Med 7:42–49
Iida N, Seo Y, Sai S, Machino-Ohtsuka T, Yamamoto M, Ishizu T et al (2016) Clinical implications of Intrarenal hemodynamic evaluation by Doppler ultrasonography in heart failure. JACC Heart Fail 4:674–682
Ishimura E, Nishizawa Y, Kawagishi T, Okuno Y, Kogawa K, Fukumoto S et al (1997) Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography. Kidney Int 51:1920–1927
Ix JH, Shlipak MG, Chertow GM, Whooley MA (2006) Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115:173–179
Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, CHARM Investigators and Committees et al (2009) Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 374:543–550
Jeong SH, Jung DC, Kim SH, Kim SH (2011) Renal venous Doppler ultrasonography in normal subjects and patients with diabetic nephropathy: value of venous impedance index measurements. J Clin Ultrasound 39:512–518
Judge P, Haynes R, Landray MJ, Baigent C (2015) Neprilysin inhibition in chronic kidney disease. Nephrol Dial Transplant 30:738–743
Kalantarinia K (2009) Novel imaging techniques in acute kidney injury. Curr Drug Targets 10:1184–1189
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150
Klein L, Massie BM, Leimberger JD, O’Connor CM, Piña IL, Adams KF Jr et al (2008) Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the outcomes of a prospective trial of intravenous Milrinone for exacerbations of chronic heart failure (OPTIME-CHF). Circ Heart Fail 1:25–33
Lassus J, Harjola VP, Sund R, Siirilä-Waris K, Melin J, Peuhkurinen K, FINN-AKVA Study Group et al (2007) Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J 28:1841–1847
Leone M, Doronzo A, Paradies V, Monitillo F, Rizzo C, Lattarulo MS et al (2016) Renal resistance index and microalbuminuria as multiparametric approach to assess renal function in heart failure: prognostic aspects. Eur J Heart Fail 18:368. Abstract
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254
Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H et al (2007) Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 18:904–912
Lubas A, Kade G, Niemczyk S (2014) Renal resistive index as a marker of vascular damage in cardiovascular diseases. Int Urol Nephrol 46:395–402
Maatman RG, Van Kuppevelt TH, Veerkamp JH (1991) Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem J 273:759–766
Massie BM, Armstrong PW, Cleland JG, Horowitz JD, Packer M, Poole-Wilson PA et al (2001) Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The assessment of treatment with Lisinopril and survival. Arch Intern Med 161:165–171
Masson S, Latini R, Milani V, Moretti L, Rossi MG, Carbonieri E, GISSI-HF Investigators et al (2010) Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial. Circ Heart Fail 3:65–72
McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A et al (2012) Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group Formula. Circ Heart Fail 5:309–314
McCormack PL (2016) Sacubitril/valsartan: a review in chronic heart failure with reduced ejection fraction. Drugs 76:387–396
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al (2014a) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993–1004
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz M, Rizkala AR et al (2014b) Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). Eur J Heart Fail 16:817–825
Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R et al (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10:188–195
Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA (2012) The role of the kidney in heart failure. Eur Heart J 33:2135–2142
Michaely HJ, Sourbron S, Dietrich O, Attenberger U, Reiser MF, Schoenberg SO (2007) Functional renal MR imaging: an overview. Abdom Imaging 32:758–771
Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ et al (2009) National Kidney Disease Education Program-IFCC working group on standardization of albumin in urine current issues in measurement and reporting of urinary albumin excretion. Clin Chem 55:24–38
Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C et al (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231–1238
Moghazi S, Jones E, Schroepple J, Arya K, McClellan W, Hennigar RA et al (2005) Correlation of renal histopathology with sonographic findings. Kidney Int 67:1515–1520
Mostbeck GH, Gössinger HD, Mallek R, Siostrzonek P, Schneider B, Tscholakoff D (1990) Effect of heart rate on Doppler measurements of resistive index in renal arteries. Radiology 175:511–513
Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor D, Starling RC et al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589–596
Murphy ME, Tublin ME (2000) Understanding the Doppler RI: impact of renal arterial distensibility on the RI in hydronephrotic ex vivo rabbit kidney model. J Ultrasound Med 19:303–314
Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO et al (1995) Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47:312–318
Niizeki T, Takeishi Y, Arimoto T, Nozaki N, Hirono O, Watanabe T et al (2008) Persistently increased serum concentration of heart-type fatty acid-binding protein predicts adverse clinical outcomes in patients with chronic heart failure. Circ J 72:109–114
Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M et al (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51:1268–1274
Noiri E, Doi K, Negishi K, Tanaka T, Hamasaki Y, Fujita T et al (2009) Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injursssssy. Am J Physiol Renal Physiol 296:F669–F679
Page JE, Morgan SH, Eastwood JB, Smith SA, Webb DJ, Dilly SA et al (1994) Ultrasound findings in renal parenchymal disease: comparison with histological appearances. Clin Radiol 49:867–870
Parolini C, Noce A, Staffolani E, Giarrizzo GF, Costanzi S, Splendiani G (2009) Renal resistive index and long term outcome in chronic nephropathies. Radiology 252:888–896
Parrinello G, Torres D, Testani JM, Almasio PL, Bellanca M et al (2015) Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction. Intern Emerg Med 10:965–972
Pierpont GL, Brown DC, Franciosa JA, Cohn JN (1980) Effect of hydralazine on renal failure in patients with congestive heart failure. Circulation 61:323–327
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709–717
Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309–1321
Platt JF, Ellis JH, Rubin JM, DiPietro MA, Sedman AB (1990) Intrarenal arterial Doppler sonography in patients with nonobstructive renal disease: correlation of resistive index with biopsy findings. AJR Am J Roentgenol 154:1223–1227
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975
Prewitt RL, Chen II, Dowell R (1982) Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Phys 243:H243–H251
Puzzovivo A, Iacoviello M, Monitillo F, Leone M, Rizzo C, Lattarulo MS et al (2016) Renal venous pattern: a new parameter for predicting cardiorenal syndrome progression. Eur J Heart Fail 18:162–163. (Abstract)
Roberts DA, Detre JA, Bolinger L, Insko EK, Lenkinski RE, Pentecost MJ et al (1995) Renal perfusion in humans: MR imaging with spin tagging of arterial water. Radiology 196:281–286
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539
Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S (2002) Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 82:S12–S22
Schanz M, Shi J, Wasser C, Alscher MD, Kimmel M (2017) Urinary [TIMP-2] × [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure. Clin Cardiol 40:485–491
Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S (2016) Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol 12:610–623
Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P et al (2007) Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 18:407–413
Schrier RW (2008) Blood urea nitrogen and serum creatinine: not married in heart failure. Circ Heart Fail 1:2–5
Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB et al (2005a) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352:2049–2060
Shlipak MG, Katz R, Fried LF, Jenny NS, Stehman-Breen C, Newman AB et al (2005b) Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol 45:268–271
Simon-Zoula SC, Hofmann L, Giger A, Vogt B, Vock P, Frey FJ et al (2006) Non-invasive monitoring of renal oxygenation using BOLD-MRI: a reproducibility study. NMR Biomed 19:84–89
Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG (2007) Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 22:1087–1092
Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA et al (2009) Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure. Clin Res Cardiol 98:121–129
Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P et al (2006) Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47:1987–1996
Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E et al (2012) Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet 380:1387–1395
Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med 354:2473–2483
Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M et al (2010) Comparative performance of the CKD epidemiology collaboration (CKD-EPI) and the modification of diet in renal disease (MDRD) study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 56:486–495
Taylor AL, Ziesche S, Yancy C, Carson P, D’Agostino R, Ferdinand K (2004) Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351:2049–2057
Taylor AL, Ziesche S, Yancy CW, Carson P, Ferdinand K, Taylor M et al (2007) African-American Heart Failure Trial Investigators. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure trial. Circulation 115:1747–1753
Testani JM, Kimmel SE, Dries DL, Coca SG (2011) Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Heart Fail 4:685–691
Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M et al (2004) Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the survival and ventricular enlargement (SAVE) study. Circulation 110:3667–3673
Tublin ME, Tessler FN, Murphy ME (1999) Correlation between renal vascular resistance, pulse pressure, and the resistive index in isolated perfused rabbit kidneys. Radiology 213:258–264
Tublin ME, Bude RO, Platt JF (2003) Review. The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol 180:885–892
Tumlin JA, Costanzo MR, Chawla LS, Herzog CA, Kellum JA, McCullough PA et al (2013) Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182:158–173
Valente MA, Hillege HL, Navis G, Voors AA, Dunselman PH, van Veldhuisen DJ et al (2014) The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the modification of diet in renal disease equation for estimating glomerular filtration rate in chronic systolic heart failure. Eur J Heart Fail 16:86–94
van de Wal RM, Asselbergs FW, Plokker HW, Smilde TD, Lok D, van Veldhuisen DJ (2005) High prevalence of microalbuminuria in chronic heart failure patients. J Card Fail 11:602–606
Vardeny O, DH W, Desai A, Rossignol P, Zannad F, Pitt B et al (2012) Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). J Am Coll Cardiol 60:2082–2089
Veerkamp JH, Paulussen RJ, Peeters RA, Maatman RG, van Moerkerk HT, van Kuppevelt TH (1990) Mol Cell Biochem 98:11–18
Verbrugge FH, Mullens W, Tang WH (2016) Management of Cardio-Renal Syndrome and Diuretic Resistance. Curr Treat Options Cardiovasc Med 18:11
Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, Morgan TJ (2003) Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 18:543–551
Winton FR (1931) The influence of venous pressure on the isolated mammalian kidney. J Physiol 72:49–61
Zannad F, McMurray JJV, Krum H, Van Veldhuisen DJ, Swedberg K, Shi H et al (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11–21
Ziaeian B, Fonarow GC, Heidenreich PA (2017) Clinical effectiveness of hydralazine-Isosorbide Dinitrate in African-American patients with heart failure. JACC Heart Fail 5:632–639
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Grande, D., Gioia, M.I., Terlizzese, P., Iacoviello, M. (2017). Heart Failure and Kidney Disease. In: Islam, M. (eds) Heart Failure: From Research to Clinical Practice. Advances in Experimental Medicine and Biology(), vol 1067. Springer, Cham. https://doi.org/10.1007/5584_2017_126
Download citation
DOI: https://doi.org/10.1007/5584_2017_126
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78279-9
Online ISBN: 978-3-319-78280-5
eBook Packages: MedicineMedicine (R0)